Skip to main content
. 2023 Jun 8;24:163. doi: 10.1186/s12882-023-03226-x

Table 2.

Subgroup analysis by region of measurement of Gal-3 levels in patients with DN and non-diabetic nephropathy (NDN)

Parameters Subgroup Study SMD 95%CI 12
Galectin-3 Asian 6 0.73 (0.58, 0.87) 15.60%
Europe 1 0.79 (0.48, 1.10) /
Africa 1 .015 (2.73, 3.56) /